|
시장보고서
상품코드
1789412
세계의 국소진통제 시장 : 약제 클래스별, 제형별, 치료 용도별, 통증 유형별, 유통별, 약제 유형별, 약제 조성별, 성별, 연령층별, 유통 채널별, 지역별(2025-2032년)Topical Analgesic Market, By Drug Class, By Formulation, By Therapeutic Application, By Pain Type, By Distribution, By Drug Type, By Drug Composition, By Gender, By Age Group, By Distribution Channel, By Geography |
||||||
세계의 국소진통제 시장은 2025년 121억 달러로 추정되며, 2032년까지 185억 6,000만 달러에 이를 것으로 예측되며, 예측 기간 중 연평균 성장률(CAGR) 6.3%로 성장할 전망입니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 121억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR: | 6.30% | 2032년 금액 예측 | 185억 6,000만 달러 |
세계 국소진통제 시장은 통증 관리 의약 산업에서 중요한 부문이며 다양한 통증 증상을 국소적으로 완화하도록 설계된 다양한 외용 치료 제품을 포함합니다. 크림, 젤, 패치, 스프레이 및 연고를 포함한 국소진통제는 경피 흡수를 통해 환부에 직접 효과적인 의약품 성분을 전달하여 전신 노출과 관련 부작용을 최소화하면서 표적을 좁힌 진통을 제공합니다. 이 시장은 관절염, 근육 긴장, 요통, 신경 병증 통증, 스포츠 관련 부상과 같은 급성 및 만성 통증 상태에 대응하며 여러 치료 용도에 사용됩니다. 근골격계 장애의 유병률 증가, 인구동태의 고령화, 비침습적 통증 관리 대체약에 대한 소비자의 취향 증가가 시장 확대에 크게 기여하고 있습니다. 시장 성장을 견인하는 주요 활성 성분은 멘톨, 캡사이신, 살리실산염, 비스테로이드성 항염증제, 리도카인 등이 있으며, 각각 진통 작용의 메커니즘이 다릅니다. 시장에는 처방약과 시판약이 모두 있으며, 다양한 소비자 요구와 건강 관리 제공업체의 취향에 대응하고 있습니다. 경피 흡수 패치와 나노 제제를 포함한 약물 전달 시스템의 기술적 진보는 제품의 효능과 환자 컴플라이언스를 향상시키고 시장 개척을 더욱 자극하며 혁신적인 치료 솔루션의 기회를 창출하고 있습니다.
시장 역학
세계의 국소진통제 시장은 지속적인 성장과 시장 확대를 뒷받침하는 여러 상호 관련 요소에 의해 주로 견인되고 있습니다. 세계 노인 인구 증가와 관절염, 섬유근통증, 신경병증 통증과 같은 만성 통증 질환의 유병률 증가는 효과적인 국소 통증 관리 솔루션에 대한 큰 수요를 낳고 있습니다. 위장 합병증 및 의존성 위험과 같은 경구 진통제의 부작용에 대한 의식이 증가함에 따라 소비자와 건강 관리 제공업체의 선호도는 전신에 대한 노출을 줄이고 국소 완화를 제공하는 국소 대체 약물로 이동하고 있습니다. 스포츠 및 피트니스 문화의 확대와 이에 따른 신체 활동 참여 증가는 스포츠 관련 부상과 근육 피로에 대응하는 국소진통제에 대한 일관된 수요를 창출하고 있습니다. 그러나 시장은 성장 궤도를 저해할 수 있는 큰 억제요인에 직면하고 있습니다. 신제품 승인을 위한 엄격한 규제 요건, 특히 처방전 제제는 시장 진입 장벽이 되어 제약 회사의 개발 비용을 증가시킵니다. 국소 제제의 침투 깊이가 제한되어 심부 통증에 대한 효능이 제한되고 시장 범위와 소비자 채용이 제한될 수 있습니다. 특히 신흥 시장에서는 소비자의 가격 감도가 높고, 고가격의 혁신적인 제품에는 과제가 있습니다. 그러나 시장 상황에는 큰 기회가 있습니다. 나노기술 기반 제제 및 침투 촉진 시스템을 포함한 고급 약물전달 기술의 개발은 치료 효과를 향상시키고 용도를 확대할 수 있는 기회를 제공합니다. 천연 소재와 유기농 진통제에 대한 수요가 증가함에 따라 식물 유래 제제 및 깨끗한 라벨 대체품에 틈새 시장이 만들어집니다. 아시아태평양과 라틴아메리카의 신흥 시장은 건강 관리 지출 증가, 통증 관리에 대한 의식 증가, 구매력이 높은 중류 계급의 인구 확대로 큰 성장 잠재력을 가지고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 국소진통제 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모와 연간 평균 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 국소진통제 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 국소진통제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 국소진통제 시장 : 약제 클래스별, 2020-2032년
- 비오피오이드계 국소진통제
- 오피오이드계 국소진통제
제5장 세계의 국소진통제 시장 : 제형별, 2020-2032년
- 크림
- 겔
- 스프레이
- 패치
- 연고 및 밤
- 기타(롤 온)
제6장 세계의 국소진통제 시장 : 치료 용도별, 2020-2032년
- 요통
- 근육통
- 목 통증
- 골관절염
- 편두통
- 두통 및 군발성 두통
- 족저근막염
- 좌골 신경통
- 활액포염
- 만성근근막통
- 늑연골염
- 급성미각장애
- 신경근 장애
- 척추 미끄럼증
- 턱관절증
- 건염
- 치통
- 당뇨병성 말초신경장애
- 류마티스 관절
- 염증성 질환
- 기타(술 후 통증 등)
제7장 세계의 국소진통제 시장 : 통증 유형별, 2020-2032년
- 급성
- 만성
제8장 세계의 국소진통제 시장 : 유통별, 2020-2032년
- 시판약(OTC)
- 처방전
제9장 세계의 국소진통제 시장 : 약제 유형별, 2020-2032년
- 브랜드
- 제네릭
제10장 세계의 국소진통제 시장 : 약제 조성별, 2020-2032년
- 단일제
- 배합제
제11장 세계의 국소진통제 시장 : 성별, 2020-2032년
- 남성
- 여성
제12장 세계의 국소진통제 시장 : 연령층별, 2020-2032년
- 성인
- 소아
- 고령자
제13장 세계의 국소진통제 시장 : 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제14장 세계의 국소진통제 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제15장 경쟁 구도
- Johnson & Johnson
- GlaxoSmithKline plc(Haleon)
- Sanofi
- Reckitt Benckiser Group plc
- Hisamitsu Pharmaceutical Co., Inc.
- Perrigo Company plc
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Boehringer Ingelheim International GmbH
- Endo International plc
- Topical BioMedics, Inc.
- The Mentholatum Company
- Pernix Therapeutics
- Hikma Pharmaceuticals PLC
제16장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제17장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
Topical Analgesic Market is estimated to be valued at USD 12.10 Bn in 2025 and is expected to reach USD 18.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 12.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.30% | 2032 Value Projection: | USD 18.56 Bn |
The global topical analgesic market represents a critical segment within the broader pain management pharmaceutical industry, encompassing a diverse range of externally applied therapeutic products designed to provide localized relief from various pain conditions. Topical analgesics, including creams, gels, patches, sprays, and ointments, deliver active pharmaceutical ingredients directly to affected areas through transdermal absorption, offering targeted pain relief while minimizing systemic exposure and associated side effects. This market serves multiple therapeutic applications, addressing acute and chronic pain conditions such as arthritis, muscle strains, back pain, neuropathic pain, and sports-related injuries. The increasing prevalence of musculoskeletal disorders, aging demographics, and growing consumer preference for non-invasive pain management alternatives have significantly contributed to market expansion. Key active ingredients driving market growth include menthol, capsaicin, salicylates, NSAIDs, and lidocaine, each offering distinct mechanisms of action for pain relief. The market encompasses both prescription and over-the-counter formulations, catering to diverse consumer needs and healthcare provider preferences. Technological advancements in drug delivery systems, including transdermal patches and nano-formulations, have enhanced product efficacy and patient compliance, further stimulating market development and creating opportunities for innovative therapeutic solutions.
Market Dynamics
The global topical analgesic market is primarily driven by several interconnected factors that collectively fuel sustained growth and market expansion. The increasing geriatric population worldwide, coupled with rising prevalence of chronic pain conditions such as arthritis, fibromyalgia, and neuropathic pain, creates substantial demand for effective topical pain management solutions. Growing awareness about the adverse effects of oral analgesics, including gastrointestinal complications and dependency risks, has shifted consumer and healthcare provider preferences toward topical alternatives that offer localized relief with reduced systemic exposure. The expanding sports and fitness culture, accompanied by increased participation in physical activities, generates consistent demand for topical analgesics addressing sports-related injuries and muscle fatigue. However, the market faces significant restraints that could impede growth trajectory. Stringent regulatory requirements for new product approvals, particularly for prescription formulations, create barriers to market entry and increase development costs for pharmaceutical companies. Limited penetration depth of topical formulations restricts their effectiveness for deep-seated pain conditions, potentially limiting market scope and consumer adoption. Price sensitivity among consumers, especially in emerging markets, poses challenges for premium-priced innovative products. Nevertheless, substantial opportunities exist within the market landscape. The development of advanced drug delivery technologies, including nanotechnology-based formulations and enhanced permeation systems, presents opportunities for improved therapeutic efficacy and expanded applications. Growing demand for natural and organic pain relief products creates niches for botanical-based formulations and clean-label alternatives. Emerging markets in Asia-Pacific and Latin America offer significant growth potential due to increasing healthcare spending, rising awareness about pain management, and expanding middle-class populations with greater purchasing power.
Key Features of the Study
- This report provides an in-depth analysis of the global topical analgesic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global topical analgesic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Novartis AG, Sanofi, Reckitt Benckiser, Teva Pharmaceutical Industries, Mylan N.V., Hisamitsu Pharmaceutical, and The Mentholatum Company.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global topical analgesic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical analgesic market.
Market Segmentation
- Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Non-Opioid Topical Analgesics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Diclofenac
- Ibuprofen
- Ketoprofen
- Piroxicam
- Capsaicin-Based Analgesics
- Methyl Salicylate (Salicylates)
- Lidocaine and Local Anesthetics
- CGRP Inhibitors
- Other Non-Opioid Agents
- Opioid-Based Topical Analgesics
- Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Creams
- Gels
- Sprays
- Patches
- Ointments & Balms
- Others (Roll-Ons)
- Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Back Pain
- Muscle Pain
- Neck Pain
- Osteoarthritis
- Migraine
- Headache and Cluster Headaches
- Plantar Fasciitis
- Sciatica
- Bursitis
- Chronic Myofascial Pain
- Costochondritis
- Gout, Acute
- Radiculopathy
- Spondylolisthesis
- Temporomandibular Joint Disorder
- Tendonitis
- Toothache
- Diabetic Peripheral Neuropathy
- Rheumatoid Arthritis
- Inflammatory Conditions
- Others (Postoperative Pain, etc.)
- Pain Type Insights (Revenue, USD Bn, 2020 - 2032)
- Acute
- Chronic
- Distribution Insights (Revenue, USD Bn, 2020 - 2032)
- Over-the-Counter (OTC)
- Prescription-Based
- Drug Type Insights (Revenue, USD Bn, 2020 - 2032)
- Brand
- Generic
- Drug Composition Insights (Revenue, USD Bn, 2020 - 2032)
- Single
- Combination
- Male Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals Pharmacy
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Johnson & Johnson
- GlaxoSmithKline plc (Haleon)
- Sanofi
- Reckitt Benckiser Group plc
- Hisamitsu Pharmaceutical Co., Inc.
- Perrigo Company plc
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Boehringer Ingelheim International GmbH
- Endo International plc
- Topical BioMedics, Inc.
- The Mentholatum Company
- Pernix Therapeutics
- Hikma Pharmaceuticals PLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Topical Analgesic Market, By Drug Class
- Global Topical Analgesic Market, By Formulation
- Global Topical Analgesic Market, By Therapeutic Application
- Global Topical Analgesic Market, By Pain Type
- Global Topical Analgesic Market, By Distribution
- Global Topical Analgesic Market, By Drug Type
- Global Topical Analgesic Market, By Drug Composition
- Global Topical Analgesic Market, By Gender
- Global Topical Analgesic Market, By Age Group
- Global Topical Analgesic Market, By Distribution Channel
- Global Topical Analgesic Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Topical Analgesic Market, By Drug Class, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Non-Opioid Topical Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Diclofenac
- Ibuprofen
- Ketoprofen
- Piroxicam
- Capsaicin-Based Analgesics
- Methyl Salicylate (Salicylates)
- Lidocaine and Local Anesthetics
- CGRP Inhibitors
- Other Non-Opioid Agents
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Opioid-Based Topical Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Topical Analgesic Market, By Formulation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ointments & Balms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Roll-Ons)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Topical Analgesic Market, By Therapeutic Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Back Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Muscle Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neck Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Osteoarthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Headache and Cluster Headaches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Plantar Fasciitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sciatica
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bursitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Myofascial Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Costochondritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gout, Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Radiculopathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Spondylolisthesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Temporomandibular Joint Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Tendonitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Toothache
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diabetic Peripheral Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rheumatoid Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inflammatory Conditions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Postoperative Pain, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Topical Analgesic Market, By Pain Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Topical Analgesic Market, By Distribution, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Over-the-Counter (OTC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prescription-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Topical Analgesic Market, By Drug Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Brand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Topical Analgesic Market, By Drug Composition, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Single
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Topical Analgesic Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Topical Analgesic Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
13. Global Topical Analgesic Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
14. Global Topical Analgesic Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
15. Competitive Landscape
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc (Haleon)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reckitt Benckiser Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hisamitsu Pharmaceutical Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Perrigo Company plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Topical BioMedics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- The Mentholatum Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pernix Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
16. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
17. References and Research Methodology
- References
- Research Methodology
- About us
